or Try an Advanced Search...

    Technical Analysis for ARVN - Arvinas, Inc.

    Grade Last Price % Change Price Change
    D 26.62 2.98% 0.77
    ARVN closed up 2.98 percent on Friday, June 28, 2024, on 4.66 times normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical ARVN trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Inside Day Range Contraction 2.98%
    Wide Bands Range Expansion 2.98%
    Slingshot Bearish Bearish Swing Setup 2.90%
    Bullish Engulfing Bullish 2.90%
    MACD Bullish Signal Line Cross Bullish 2.90%
    Wide Bands Range Expansion 2.90%
    Oversold Stochastic Weakness 2.90%
    Older End-of-Day Signals for ARVN ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 1 day ago
    Down 1% 1 day ago
    Rose Above Previous Day's High 1 day ago
    Up 1% 1 day ago
    60 Minute Opening Range Breakout 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ARVN Chart by TradingView
    Basic chart:

    Profile

    Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera

    Is ARVN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Arvinas, Inc. (ARVN): Why Did Analysts Give This Small-Cap Stock a Strong Buy Rating?
    Jun 24 Arvinas appoints Andrew Saik as CFO
    Jun 24 Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer
    Jun 24 Cytek Biosciences (CTKB) Moves 5.1% Higher: Will This Strength Last?
    Jun 21 Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2
    Jun 17 Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer
    May 23 Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress
    May 23 It Looks Like Arvinas, Inc.'s (NASDAQ:ARVN) CEO May Expect Their Salary To Be Put Under The Microscope
    May 16 Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
    May 11 Arvinas, Inc. (NASDAQ:ARVN) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
    See more ARVN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 53.08
    52 Week Low 13.57
    Average Volume 871,073
    200-Day Moving Average 32.21
    50-Day Moving Average 30.53
    20-Day Moving Average 26.62
    10-Day Moving Average 25.37
    Average True Range 1.55
    RSI (14) 42.53
    ADX 23.2
    +DI 21.52
    -DI 24.72
    Chandelier Exit (Long, 3 ATRs) 30.68
    Chandelier Exit (Short, 3 ATRs) 28.39
    Upper Bollinger Bands 30.44
    Lower Bollinger Band 22.81
    Percent B (%b) 0.5
    BandWidth 28.66
    MACD Line -1.70
    MACD Signal Line -1.97
    MACD Histogram 0.264
    Fundamentals Value
    Market Cap 1.46 Billion
    Num Shares 55 Million
    EPS -5.52
    Price-to-Earnings (P/E) Ratio -4.82
    Price-to-Sales 17.22
    Price-to-Book 6.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 28.48
    Resistance 3 (R3) 28.31 27.53 28.17
    Resistance 2 (R2) 27.53 27.05 27.61 28.07
    Resistance 1 (R1) 27.07 26.76 27.30 27.24 27.96
    Pivot Point 26.29 26.29 26.40 26.37 26.29
    Support 1 (S1) 25.83 25.81 26.06 26.00 25.28
    Support 2 (S2) 25.05 25.52 25.13 25.17
    Support 3 (S3) 24.59 25.05 25.07
    Support 4 (S4) 24.76